Ontario Bioscience Innovation Organization (OBIO®) invites Canadian health science companies commercializing products and services in therapeutics, medical devices, diagnostics, digital health and health IT to submit an application to pitch in-person to global investors at the 2024 OBIO® Investment Summit (OIS) in Toronto on February 14-16. The Summit will highlight Canada’s most promising early-stage and venture-backed companies across a full spectrum of technologies: therapeutics, medical devices, diagnostics, digital health and health IT. Companies chosen to present at the OIS have collectively raised $1.6 B and licensed out $2B since 2018.